D-0325-2015 Class II Terminated

Recalled by Zydus Pharmaceuticals USA Inc — Pennington, NJ

FDA drug recall D-0325-2015 was initiated by Zydus Pharmaceuticals USA Inc on Dec 23, 2014 and is designated Class II. Reason for recall: Failed Tablet/Capsule Specifications: Recall due to wet and/or leaking capsules. The recall status is terminated (terminated Sep 22, 2017). Affected quantity: 19,536 units.

Recall details

Product Type
Drugs
Report Date
Dec 31, 2014
Initiation Date
Dec 23, 2014
Termination Date
Sep 22, 2017
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
19,536 units

Product description

Benzonatate Capsules, USP, 100 mg, Rx only, Manufactured by: Cadila Healthcare Ltd, Ahmedabad, India; Distributed by: Zydus Pharmaceuticals USA, In, Pennington, NJ USA 08534; 100-bottle capsules - NDC 68382-247-01 500-bottle capsules - NDC 68382-247-05

Reason for recall

Failed Tablet/Capsule Specifications: Recall due to wet and/or leaking capsules.

Distribution pattern

Nationwide

Code information

Lot #: MP2625, MP2626, MP2627 Exp 2/16; MP4875, MP4876, MP4877, MP4878 Exp 4/16; MP6482, MP6483, MP6484, MP6493, MP6494 Exp 6/16

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0325-2015
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0325-2015. Report a data issue: hello@regdatalab.com.